NCT01895231View on ClinicalTrials.gov

A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors

PHASE3CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Iron-deficiency

Interventions

DRUG

Iron isomaltoside 1000 (Monofer®)

DRUG

Placebo

Trial Locations (1)

Unknown

Copenhagen

Sponsors

Lead Sponsor

Pharmacosmos A/S

All Listed Sponsors

collaborator

Max Neeman

UNKNOWN

lead

Pharmacosmos A/S

INDUSTRY